Inventor · disambiguated record
Cheng-Lun Ku
Also filed as: KU CHENG-LUN
5 granted patents·1 pending application·8 citations·filing 2016–2023
70Inventor score
Files withELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD4ELIXIRON IMMUNOTHERAPEUTICS HONG KONG1UNIV CHANG GUNG1
Top patents by PatentIndex Score
6 records- 0187US10813974B2Methods for treatment of HBV infectionELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2020·Granted Oct 27, 2020·3 cites·28 claims
- 0280US10968274B2Anti-interferon gamma antibodies and uses thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2018·Granted Apr 6, 2021·4 cites·9 claims
- 0367US10273278B2Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application thereforUNIV CHANG GUNG·Filed 2016·Granted Apr 30, 2019·1 cites·5 claims
- 0465US12398205B2Anti-interferon gamma antibodies and uses thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2021·Granted Aug 26, 2025·0 cites·14 claims
- 0556US2025320288A1Method of treating vitiligo with interferon-gamma antibodyELIXIRON IMMUNOTHERAPEUTICS HONG KONG·Filed 2023·Application pending·0 cites
- 0653US12291567B2Antibodies to granulocyte-macrophage colony stimulating factor and uses thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2021·Granted May 6, 2025·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Cheng-Lun Ku files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →